Skip to main content

Table 5 Esketamine administration scheme

From: The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report

Phase

Period

Frequency of administration

Dose

Induction

First month

2 times/week

56 mg

Maintenance

Second month

1 time/week

56 mg

Maintenance

Third month and longer

1 time/2 weeks

56 mg